Genomics

Dataset Information

0

IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [E2F1-3 KD in PANC-1 (polyA RNA)]

ABSTRACT: IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [E2F1-3 KD in PANC-1 (polyA RNA)]

PROVIDER: PRJNA612007 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR11290608_1.fastq.gz Fastqsanger.gz
SRR11290608_2.fastq.gz Fastqsanger.gz
SRR11290609_1.fastq.gz Fastqsanger.gz
SRR11290609_2.fastq.gz Fastqsanger.gz
SRR11290610_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 12

Similar Datasets

Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in PANC-1 (total RNA)]
| PRJNA612006 | ENA
Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [E2F1-3 KD in PANC-1 (polyA RNA)]
2020-06-17 | GSE146804 | GEO
Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in PANC-1 (total RNA)]
2020-06-17 | GSE146805 | GEO
Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [METTL KD in PANC-1 (polyA RNA)]
| PRJNA612005 | ENA
Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [METTL KD in PANC-1 (polyA RNA)]
2020-06-17 | GSE146806 | GEO
Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer
| PRJNA612000 | ENA
Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in MV3 (total RNA)]
| PRJNA612008 | ENA
Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in HepG2 (polyA RNA)]
| PRJNA612009 | ENA
Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in A549 (polyA RNA)]
| PRJNA610832 | ENA
Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KO in A-549 (polyA RNA)]
| PRJNA610834 | ENA